Neuromodulator
Neurodiagnostics company receives US patent for electrode interface device
A firm specializing in brain-computer interface has received a U.S. patent for its Medusa Electrode, which translates specific neuromodulation connections into universal electroencephalography plugs.
Grant will enable firm to use neuromodulation system in stroke recovery study
An Illinois-based neuro tech company has announced the reception of a multimillion-dollar grant to support a post-stroke recovery study at the Cleveland Clinic with its novel micro-neuromodulation platform.
VIDEO: Treatment options for patients with IBS-C, CIC
Anthony Lembo, MD, Director of Research for Cleveland Clinic's Digestive Disease & Surgery Institute, discusses the diagnostic process for patients presenting with constipation; approaching management of patients with IBS-C and CIC; treatment options and recent therapeutic advances; health disparities; and important challenges of care.
Newer areas of research providing updated tools to treat dry eye disease
Neuromodulation and neurostimulation are close cousins, but they are not the same thing.
Neurostimulation, neuromodulation offer exciting new approaches for dry eye
Artificial tears have long been the first option for patients with dry eye disease, but they only offer a partial solution.
First patient treated in study of neuromodulation device for Lennox-Gastaut Syndrome
NeuroPace Inc. announced that the first patient with Lennox-Gastaut Syndrome was treated in its investigational device exemption feasibility study, which will evaluate the company’s neuromodulation technology.
New version of implanted neuromodulation device for HF launched
CVRx announced it has launched a next-generation version of its neuromodulation device to treat HF symptoms.
Return to function, pain reduction primary goals of acute migraine treatment
LAS VEGAS — Rapid reduction of symptoms and pain, achieved through the most effective drug and nondrug treatments, is a key priority for patients who experience acute migraines, according to a presenter at BRAINWeek 2022.
Next-gen programmer for HF symptom neuromodulation device launched
CVRx Inc. announced the launch of its next-generation programmer for its implantable pulse neuromodulation generator to treat HF symptoms.
Neuromodulation therapy may improve treatment-resistant depression
A high dose of intermittent theta-burst stimulation with functional-connectivity-guided targeting outperformed sham stimulation for treatment-resistant depression.